Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 5 33-5, 2005, Pages

  Mora, Ana L ^a,b   Woods, Charles R ^a   Garcia, Anapatricia ^a   Xu, Jianguo ^a   Rojas, Mauricio ^a   Speck, Samuel H ^a   Roman, Jesse ^a   Brigham, Kenneth L ^a   Stecenko, Arlene A ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal disease model; Interstitial lung diseases; T helper 2; Virus diseases

Indexed keywords

COLLAGEN; GAMMA INTERFERON RECEPTOR; MATRILYSIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL TRANSFORMATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ELECTRON MICROSCOPY; FAMILIAL DISEASE; FIBROSING ALVEOLITIS; HERPES VIRUS; IDIOPATHIC DISEASE; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG INFECTION; MOUSE; MOUSE STRAIN; MURINE GAMMA HERPESVIRUS 68; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TH2 CELL; TIDAL VOLUME; VIRUS PATHOGENESIS;

ANIMALS; BASE SEQUENCE; COLLAGEN; CYTOKINES; DNA, COMPLEMENTARY; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 7; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY FIBROSIS; RECEPTORS, INTERFERON; RHADINOVIRUS; TH2 CELLS;

EID: 27144534791     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00007.2005     Document Type: Article

References (45)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
2. Boelen A, Kwakkel J, Barends M, de Rond L, Dormans J, and Kimman T. Effect of lack of interleukin-4, interleukin-12, interleukin-18, or the interferon-γ receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J Med Virol 66: 552-560, 2002.
3. Chen ES, Greenlee BM, Wills-Karp M, and Moller DR. Attenuation of lung inflammation and fibrosis in interferon-γ-deficient mice after intratracheal bleomycin. Am J Respir Cell Mol Biol 24: 545-555, 2001.
4. Chen HD, Fraire AE, Joris I, Welsh RM, and Selin LK. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 163: 1341-1355, 2003.
5. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, and Doglioni C. Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162: 1495-1502, 2003.
6. Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, and Voelkel NF. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349: 1113-1122, 2003.
7. Cosgrove GP, Schwarz MI, Geraci MW, Brown KK, and Worthen GS. Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis. Chest 121: 25S-26S, 2002.
8. Dal Canto AJ, Virgin HW, and Speck SH. Ongoing viral replication is required for γherpesvirus 68-induced vascular damage. J Virol 74: 11304-11310, 2000.
9. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, and Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742, 1993.
10. Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, Sasano H, Kondo T, and Nukiwa T. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 169: 1203-1208, 2004.
11. Ebrahimi B, Dutia BM, Brownstein DG, and Nash AA. Murine γherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-γ receptor knockout mice. Am J Pathol 158: 2117-2125, 2001.
12. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, and Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50: 1234-1239, 1995.
13. Flano E, Husain SM, Sample JT, Woodland DL, and Blackman MA. Latent murine γ-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165: 1074-1081, 2000.
14. Flano E, Kim IJ, Moore J, Woodland DL, and Blackman MA. Differential γ-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170: 3828-3834, 2003.
15. Geiser T. Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair? Swiss Med Wkly 133: 405-411, 2003.
16. Glasser SW, Detmer EA, Ikegami M, Na CL, Stahlman MT, and Whitsett JA. Pneumonitis and emphysema in SP-C gene targeted mice. J Biol Chem 278: 14291-14298, 2003.
17. Homer RJ, Zheng T, Chupp G, He S, Zhu Z, Chen Q, Ma B, Hite RD, Gobran LI, Rooney SA, and Elias JA. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 283: L52-L59, 2002.
18. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, and Aguet M. Immune response in mice that lack the interferon-γ receptor. Science 259: 1742-1745, 1993.
19. Jain-Vora S, Wert SE, Temann UA, Rankin JA, and Whitsett JA. Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am J Respir Cell Mol Biol 17: 541-551, 1997.
20. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, and Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5: 155-162, 1991.
21. Lok SS, Haider Y, Howell D, Stewart JP, Hasleton PS, and Egan JJ. Murine γherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J 20: 1228-1232, 2002.
22. Magro CM, Allen J, Pope-Harman A, Waldman WJ, Moh P, Rothrauff S, and Ross P Jr. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol 119: 556-567, 2003.
23. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, and Blumberg RS. The transcription factor T-Bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195: 1129-1143, 2002.
24. Price GE, Gaszewska-Mastarlarz A, and Moskophidis D. The role of α/β and γ interferons in development of immunity to influenza A virus in mice. J Virol 74: 3996-4003, 2000.
25. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, and King TE Jr. A placebo-controlled trial of interferon γ-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350: 125-133, 2004.
26. Segel MJ, Izbicki G, Cohen PY, Or R, Christensen TG, Wallach-Dayan SB, and Breuer R. Role of interferon-γ in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285: L1255-L1262, 2003.
27. Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS, and Floros J. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113: 542-550, 2003.
28. Selman M and Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 29: S93-S97, 2003.
29. Sempowski GD, Derdak S, and Phipps RP. Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 167: 290-296, 1996.
30. Stewart JP, Egan JJ, Ross AJ, Kelly BG, Lok SS, Hasleton PS, and Woodcock AA. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 159: 1336-1341, 1999.
31. Stewart JP, Usherwood EJ, Ross A, Dyson H, and Nash T. Lung epithelial cells are a major site of murine γherpesvirus persistence. J Exp Med 187: 1941-1951, 1998.
32. Sunil-Chandra NP, Efstathiou S, and Nash AA. Murine γherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73: 3275-3279, 1992.
33. Svetic A, Finkelman FD, Jian YC, Dieffenbach CW, Scott DE, McCarthy KF, Steinberg AD, and Cause WC. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 147: 2391-2397, 1991.
34. Takeda K, Miyahara N, Rha YH, Taube C, Yang ES, Joetham A, Kodama T, Balhorn AM, Dakhama A, Duez C, Evans AJ, Voelker DR, and Gelfand EW. Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med 168: 783-789, 2003.
35. Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, Brigham KL, Oates JA Jr, Loyd JE, and Stecenko AA. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 41: 2633-2640, 2003.
36. Thomas AQ, Lane K, Phillips J III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman M, and Loyd JE. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165: 1322-1328, 2002.
37. Vergnon JM, Vincent M, de The G, Mornex JF, Weynants P, and Brune J. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? Lancet 2: 768-771, 1984.
38. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Week KE, Dal Canto AJ, and Speck SH. Complete sequence and genomic analysis of murine γherpesvirus 68. J Virol 71: 5894-5904, 1997.
39. Wallace WA and Howie SE. Immunoreactive interleukin 4 and interferon-γ expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 187: 475-480, 1999.
40. Wallace WA, Ramage EA, Lamb D, and Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 101: 436-441, 1995.
41. Week KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, Speck SH, and Virgin HW. Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease. Nat Med 3: 1346-1353, 1997.
42. Week KE, Kim SS, Virgin HI, and Speck SH. Macrophages are the major reservoir of latent murine γherpesvirus 68 in peritoneal cells. J Virol 73: 3273-3283, 1999.
43. Weinberg JB, Lutzke ML, Alfinito R, and Rochford R. Mouse strain differences in the chemokine response to acute lung infection with a murine γherpesvirus. Virol Immunol 17: 69-77, 2004.
44. Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, and Khalil N. Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285: L527-L539, 2003.
45. Ziesche R, Hofbauer E, Wittmann K, Petkov V, and Block LH. A preliminary study of long-term treatment with Interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341: 1264-1269, 1999.